Nanotechnology platforms and physiological challenges for cancer therapeutics
- 24 April 2007
- journal article
- review article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 3 (2), 103-110
- https://doi.org/10.1016/j.nano.2006.12.002
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interferenceBiomaterials, 2006
- Protease-Modulated Cellular Uptake of Quantum DotsNano Letters, 2006
- Proteolytic Actuation of Nanoparticle Self‐AssemblyAngewandte Chemie International Edition, 2006
- Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus VectorCancer Research, 2006
- PAMAM Dendrimer-Based Multifunctional Conjugate for Cancer Therapy: Synthesis, Characterization, and FunctionalityBiomacromolecules, 2006
- Immunotargeted Nanoshells for Integrated Cancer Imaging and TherapyNano Letters, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticlesCancer Letters, 2004
- On the formulation of pH-sensitive liposomes with long circulation timesAdvanced Drug Delivery Reviews, 2004
- PegylationClinical Pharmacokinetics, 2001